Kolon TissueGene, Inc. (KOSDAQ:950160)
South Korea · Delayed Price · Currency is KRW 101,500
+1,400 (1.40%)
Apr 3, 2026, 10:10 AM KST
Kolon TissueGene Market Cap
Kolon TissueGene has a market cap or net worth of 8.42 trillion as of April 2, 2026. Its market cap has increased by 166.29% in one year.
Market Cap
8.42T
Enterprise Value
8.42T
Revenue
5.16B
Ranking
n/a
PE Ratio
n/a
Stock Price
101,500.00
Market Cap Chart
Since November 6, 2017, Kolon TissueGene's market cap has increased from 2.58T to 8.42T, an increase of 226.70%. That is a compound annual growth rate of 15.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 8.42T | 27.15% |
| Dec 30, 2025 | 6.62T | 258.54% |
| Dec 30, 2024 | 1.85T | 181.73% |
| Dec 28, 2023 | 655.80B | 7.08% |
| Dec 29, 2022 | 612.43B | -76.74% |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 6, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ALTEOGEN | 18.97T |
| Samsung Epis Holdings | 12.67T |
| SK Biopharmaceuticals | 7.63T |
| LigaChem Biosciences | 7.24T |
| HLB Co., Ltd. | 7.11T |
| Peptron | 6.94T |
| Voronoi | 5.76T |
| OliX Pharmaceuticals | 3.76T |